Risk factors

XBiotech (XBIT) risk factors

Item 1A of every XBiotech Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open XBIT in Gloom →
XBiotech's chart, financials and news, free in your browser.Open XBIT in Gloom →
  • FY2025 10-K risk factors
    51 risks10 new2 dropped9 reworded

    Founder John Simard retired as CEO in December 2025, shifting to a consulting role.

    Filed Mar 13, 2026
  • FY2024 10-K risk factors
    43 risks

    XBiotech faces high concentration risk around CEO John Simard, its pipeline, and milestone payments from the Janssen Transaction for Bermekimab.

    Filed Mar 18, 2025